Lion study terbinafine

doi: 10. The high cure rates of terbinafine against dermatophytes, as shown in many studies since its launch in the 1990s, together with lack of clinically significant drug interactions and well established safety record, indicate the use of continuous oral terbinafine as the top choice for the treatment of onychomycosis in most patients

2024-03-28
    Ethical issues with exelon
  1. 1994;130(43):29-31
  2. Sigurgeirsson BBillstein SRantanen T et al
  3. Objectives: To perform a 4
  4. The LION Study Group
  5. Subjects: 496 patients
  6. Objectives To perform a 4
  7. e
  8. 2
  9. PMID: 10205099
  10. Prescription initiale hospitalière
  11. 24